Trevena
TRVN
#11371
Rank
ยฃ0 M
Marketcap
ยฃ0.0003818
Share price
0.00%
Change (1 day)
-95.01%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -ยฃ24.27 Million

According to Trevena's latest financial reports the company's current earnings are ยฃ0.54 Million. In 2023 the company made an earning of -ยฃ27.75 Million, an increase over its 2022 earnings that were of -ยฃ40.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ24.27 Million-12.53%
2023 -ยฃ27.75 Million-30.69%
2022 -ยฃ40.03 Million1.38%
2021 -ยฃ39.49 Million78.04%
2020 -ยฃ22.18 Million21.3%
2019 -ยฃ18.29 Million-13.91%
2018 -ยฃ21.24 Million-59.75%
2017 -ยฃ52.76 Million-31.77%
2016 -ยฃ77.33 Million101.73%
2015 -ยฃ38.34 Million1.14%
2014 -ยฃ37.9 Million114.83%
2013 -ยฃ17.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
ยฃ8.43 B-35,687.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.13 B-21,747.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-ยฃ60.63 Million 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.6 Billion 2,404.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-ยฃ7.86 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-ยฃ47.96 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-ยฃ0.48 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA